File(s) under permanent embargo
Biological and computational evaluation of resveratrol inhibitors against Alzheimer’s disease
journal contribution
posted on 2023-06-08, 21:37 authored by Catherine Koukoulitsa, Carolina Villalonga-Barber, Robert Csonka, Xanthippi Alexi, Georgios Leonis, Dimitris Dellis, Elizabeth Hamelink, Oscar Belda, Barry R Steele, Maria Micha-Screttas, Michael N Alexis, Manthos G Papadopoulos, Thomas MavromoustakosIt has been reported that beta amyloid induces production of radical oxygen species and oxidative stress in neuronal cells, which in turn upregulates ß-secretase (BACE-1) expression and beta amyloid levels, thereby propagating oxidative stress and increasing neuronal injury. A series of resveratrol derivatives, known to be inhibitors of oxidative stress-induced neuronal cell death (oxytosis) were biologically evaluated against BACE-1 using homogeneous time-resolved fluorescence (TRF) assay. Correlation between oxytosis inhibitory and BACE-1 inhibitory activity of resveratrol derivatives was statistically significant, supporting the notion that BACE-1 may act as pivotal mediator of neuronal cell oxytosis. Four of the biologically evaluated resveratrol analogs demonstrated considerably higher activity than resveratrol in either assay. The discovery of some “hits” led us to initiate detailed docking studies associated with Molecular Dynamics in order to provide a plausible explanation for the experimental results and understand their molecular basis of action.
History
Publication status
- Published
File Version
- Published version
Journal
Journal of Enzyme Inhibition and Medicinal ChemistryISSN
1475-6366Publisher
Informa HealthcareExternal DOI
Issue
1Volume
31Page range
67-77Department affiliated with
- Chemistry Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2015-07-14First Compliant Deposit (FCD) Date
2015-07-14Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC